SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021373
Filing Date
2022-08-05
Accepted
2022-08-05 16:23:24
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcrx-20220630.htm   iXBRL 10-Q 1576973
2 EX-10.3 exhibit103.htm EX-10.3 45398
3 EX-10.4 exhibit104.htm EX-10.4 43516
4 EX-10.5 exhibit10.htm EX-10.5 689
5 EX-31.1 bcrx-20220630xexx311.htm EX-31.1 9590
6 EX-31.2 bcrx-20220630xexx312.htm EX-31.2 9564
7 EX-32.1 bcrx-20220630xexx321.htm EX-32.1 4723
8 EX-32.2 bcrx-20220630xexx322.htm EX-32.2 4664
14 exhibit10001.jpg GRAPHIC 223155
  Complete submission text file 0001628280-22-021373.txt   7665566

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20220630.xsd EX-101.SCH 63013
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20220630_cal.xml EX-101.CAL 49643
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20220630_def.xml EX-101.DEF 276099
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20220630_lab.xml EX-101.LAB 664276
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20220630_pre.xml EX-101.PRE 394307
63 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20220630_htm.xml XML 1154347
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 221141179
SIC: 2836 Biological Products, (No Diagnostic Substances)